SCHEMBL20042753

SCHEMBL20042753

Cc1nc2c(c(N3CCC3)n1)[C@@H](C)N(C(=O)c1ccc(F)c(C#N)c1)C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MAPK1 P28482 1/20 0.36
TACR3 P29371 6/20 0.35
KCNH2 Q12809 2/20 0.35
GRM5 P41594 2/20 0.35
RORC P51449 1/20 0.35
TSHR P16473 2/20 0.34
CASP1 P29466 2/20 0.34
CASP7 P55210 2/20 0.34
HSD17B10 Q99714 2/20 0.34
USP2 O75604 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TACR2 P21452 2/20 0.34
P2RX7 Q99572 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042897 0.91 ALDH1A1 (0.40) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL20043017 0.89 ALDH1A1 (0.36) ALDH1A1KDM4EMEN1KMT2AMAPK1
SCHEMBL20042900 0.88 TACR3 (0.38) ALDH1A1TACR3KCNH2TACR2P2RX7
SCHEMBL20042852 0.86 TACR3 (0.47) TACR3KCNH2TACR2P2RX7TACR1
SCHEMBL20042767 0.85 TACR3 (0.44) ALDH1A1TACR3KCNH2GRM5P2RX7
SCHEMBL20042727 0.84 TACR3 (0.47) TACR3KCNH2TACR2P2RX7TACR1
SCHEMBL20042878 0.84 TACR3 (0.47) TACR3KCNH2TACR2P2RX7TACR1
SCHEMBL20042958 0.83 TACR3 (0.42) TACR3KCNH2TACR2
SCHEMBL20042865 0.83 TACR3 (0.42) TACR3KCNH2TACR2
SCHEMBL20042843 0.83 GRM5 (0.40) GRM5P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed